Sponsor:
Edgewise Therapeutics, Inc.
Code:
NCT05291091
Conditions
Becker Muscular Dystrophy
Eligibility Criteria
Sex: Male
Age: 12 - 50
Healthy Volunteers: Not accepted
Interventions
Sevasemten 10 mg
Sevasemten 5 mg
Sevasemten 12.5 mg
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations